Literature DB >> 20206546

What is the evidence for the use of high flow nasal cannula oxygen in adult patients admitted to critical care units? A systematic review.

Jodie Kernick1, Judy Magarey.   

Abstract

BACKGROUND: Humidified high flow nasal cannula oxygen therapy is increasingly available in Australian adult intensive care units. Its use in paediatric populations has been extensively studied and has shown positive effects however its clinical effectiveness in adults has not been established.
PURPOSE: A systematic review of the literature was conducted to critique current evidence, inform nursing practice and make recommendations for nursing research.
METHODS: An extensive search strategy identified clinical studies comparing standard oxygen therapy with high flow therapy in critical care units. Two reviewers independently assessed articles for eligibility, methodological quality and inclusion. Outcomes of interest included oxygenation, ventilation, work of breathing, positive airway pressure, patient comfort and long term effect. A narrative synthesis was conducted to describe the emerging evidence.
FINDINGS: Eight studies were included for review. All were abstracts or poster presentations from scientific meetings therefore the quality of data available for analysis was poor. Findings indicated there was preliminary evidence to support the use of high flow therapy to optimise oxygenation in adults. This therapy may reduce the effort of breathing and provide augmented airway pressures. Patients described the therapy as comfortable. No definitive evidence supported the claim that ventilation is improved or conclusively demonstrated a long-term effect.
CONCLUSION: Humidified high flow nasal cannula may be used as an intermediate therapy to improve oxygenation in adult critical care patients. Further research is required to determine the duration of effect of the therapy, identify the patient population for whom it is most beneficial and evaluate long-term outcomes; to enable definitive recommendations for practice to be made. Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20206546     DOI: 10.1016/j.aucc.2010.01.001

Source DB:  PubMed          Journal:  Aust Crit Care        ISSN: 1036-7314            Impact factor:   2.737


  20 in total

1.  Prognostic impact of high-flow nasal cannula oxygen supply in an ICU patient with pulmonary fibrosis complicated by acute respiratory failure.

Authors:  Alexandre Boyer; Frédéric Vargas; Maricke Delacre; Mélanie Saint-Léger; Benjamin Clouzeau; Gilles Hilbert; Didier Gruson
Journal:  Intensive Care Med       Date:  2010-09-18       Impact factor: 17.440

2.  Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials.

Authors:  Xiaofeng Ou; Yusi Hua; Jin Liu; Cansheng Gong; Wenling Zhao
Journal:  CMAJ       Date:  2017-02-21       Impact factor: 8.262

Review 3.  Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature.

Authors:  Jan Hau Lee; Kyle J Rehder; Lee Williford; Ira M Cheifetz; David A Turner
Journal:  Intensive Care Med       Date:  2012-11-10       Impact factor: 17.440

Review 4.  High-flow nasal cannulae for respiratory support in adult intensive care patients.

Authors:  Amanda Corley; Claire M Rickard; Leanne M Aitken; Amy Johnston; Adrian Barnett; John F Fraser; Sharon R Lewis; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-05-30

5.  Parallel-group, randomised, controlled, non-inferiority trial of high-flow nasal cannula versus non-invasive ventilation for emergency patients with acute cardiogenic pulmonary oedema: study protocol.

Authors:  Onlak Ruangsomboon; Nattakarn Praphruetkit; Apichaya Monsomboon
Journal:  BMJ Open       Date:  2022-07-07       Impact factor: 3.006

6.  Heated humidified high-flow nasal cannula versus low-flow nasal cannula as weaning mode from nasal CPAP in infants ≤28 weeks of gestation.

Authors:  Jose Ramon Fernandez-Alvarez; Rashmi Shreyans Gandhi; Philip Amess; Liam Mahoney; Ryan Watkins; Heike Rabe
Journal:  Eur J Pediatr       Date:  2013-08-14       Impact factor: 3.183

7.  Non-invasive ventilation in immunocompromised patients with acute hypoxemic respiratory failure.

Authors:  Lorenzo Del Sorbo; Angela Jerath; Martin Dres; Matteo Parotto
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

8.  High-flow nasal cannulae for respiratory support in adult intensive care patients.

Authors:  Sharon R Lewis; Philip E Baker; Roses Parker; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-03-04

9.  Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial.

Authors:  Onlak Ruangsomboon; Chok Limsuwat; Nattakarn Praphruetkit; Apichaya Monsomboon; Tipa Chakorn
Journal:  Acad Emerg Med       Date:  2020-12-22       Impact factor: 3.451

10.  High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy.

Authors:  Umberto Lucangelo; Fabio Giuseppe Vassallo; Emanuele Marras; Massimo Ferluga; Elena Beziza; Lucia Comuzzi; Giorgio Berlot; Walter Araujo Zin
Journal:  Crit Care Res Pract       Date:  2012-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.